Here’s my guide to navigate the #ACC25 trials, coming this weekend and featured in many journals with a (very) high impact factor. 1. WARRIOR = Intensive medical therapy in women with ANOCA/INOCA 2. STRIDE = Semaglutide in type 2 diabetes and peripheral artery disease 3. API-CAT

🚨In #STRIDE, 💉#semaglutide improved walking distance, symptoms, and QoL in people with #T2D + #PAD🚶‍♂️ First RCT to show functional benefit in PAD with #GLP1RA👏 Studies are needed to explore mechanisms and assess efficacy in #PAD patients without #T2D 📄

Our residents and chief residents presenting their research work and enjoying ACC.25! American College of Cardiology MedStar Health Internal Medicine Residency Program #ACC25

One of the most important trials at American College of Cardiology #ACC25 ! Compared fluid restriction to liberal approach in #HeartFailure. Why? This affects individuals w/HF EVERY DAY! ✨No benefit of Fluid Restriction ✨No HARM for liberal fluid intake ✨Improved QOL in liberal fluid intake

Original Article: Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism (API-CAT trial) nej.md/41YkRZK Editorial: Cancer-Associated Venous Thromboembolism — Beyond 6 Months nej.md/4iB6wcA #ACC25 | American College of Cardiology

Fantastic SCAD session today at #ACC25. Full house. Great presentations that are practical that aids contemporary practice

New NEJM #ACC25 The global impact of 5 cardiovascular risk factors (BP, cholesterol, obesity, diabetes, smoking) on life expectancy in men and women nejm.org/doi/full/10.10…

A #JACCAdvances updated network meta-analysis confirms that SAPT remains the safest choice for pts w/out indication for anticoagulation, significantly reducing 🩸 risk w/out 📈 mortality, #cvMI, or stroke risks. Personalized care remains essential. jacc.org/doi/10.1016/j.… #ACC25

Original Article: Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a) (ALPACA trial) nej.md/4kWjJyn #ACC25 | American College of Cardiology

ACC 2025 LATE BREAKING CLINICAL TRIALS - One LINER SUMMARY 📸 AT A GLANCE ⭐️ What a phenomenal scientific meeting! Congratulations to all the presenters &research leaders for yet another fantastic year of innovation & research. 🫀❤️ 😊 #ACC2025 American College of Cardiology UW-Madison Division of Cardiovascular Medicine CardioNerds

Lucky to sit down with Philippe Genereux to discuss new insights from the EARLY TAVR trial and the incidence and impact of Acute Valve Syndrome Will be interesting to see how this data affects the management of AS and timing of TAVR moving forward American College of Cardiology #ACC25

The Optimal Intensity of Extended-Duration Anticoagulation After Cancer-Associated VTE Behnood Bikdeli comments on practice-changing research presented at the ACC Scientific Sessions. jwat.ch/43RRA5B #ACC25 NEJM

People with heart disease need to exercise, but what should their programming consist of? Our review published today highlights specific evidence based protocols! MedStar Health Internal Medicine Residency Program Lida Koskina Shiavax J. Rao #HeartFailure link.springer.com/article/10.100…

Exercise is a powerful, underused therapy for ischemic cardiomyopathy. This review highlights evidence-based regimens, gaps in current guidelines, and how tech-enabled rehab could boost outcomes and adherence (link.springer.com/article/10.100…). Now in #HREV.

📊 A global study shows women cardiologists face higher rates of mental health conditions (33.7% vs 26.3%) & suicide ideation than men. This highlights the urgent need to provide better support for women in cardiology. sciencedirect.com/science/articl… #MentalHealthAwarenessMonth #WIC

From the latest issue: In this insightful review, Willems and colleagues evaluate the prognostic performance of several bedside tests for predicting ulcer healing after minor amputations. buff.ly/3Wutklf #PeripheralArteryDisease

Online First! In this comprehensive review, Giao and colleagues summarize current literature on the safety and effectiveness of endovascular renal denervation for management of patients with hypertension. doi.org/10.1177/135886… #Hypertension #RenalDenervation

We’re excited to share enrollment for HI-PEITHO is now complete! With 544 patients enrolled across 72 sites in the United States in Europe, this landmark trial compares EKOS (Ultrasound Assisted Thrombolysis) with Anticoagulation vs Anticoagulation Alone in the treatment of